• Global Cellulite Treatment market revenue is expected to expand at impressive CAGR of 7.7% over the forecast period to reach value of US$ 5,227.7 Mn by 2028 end
• In terms of revenue, Non-invasive treatment procedure segment is projected to remain the dominant it is expected to gain traction due to high demand from specialized dermatology clinics and hospitals
• Soft cellulite segment is expected to gain significant market share over the forecast period due to high number of obesity population
• Among all end users, Specialized dermatology clinics dominated the global market by 50.1% share in 2018
• North America is considered to be a lucrative marketplace for the global cellulite treatment market and estimated to retain over 39.8% (2018) of the global market share during 2018–2028
Macro-economic Factors:
• Increasing Cosmetic Surgery Procedures
• Rise In Global Annual Disposable Income Per Capita
Drivers:
• Increasing self awareness among the consumers
• Rising prevalence of fat deposition related disorders requiring better treatment options
Trends:
• Increasing preference for non-surgical procedures in U.S., the largest market
• Increasing inclination towards aesthetic procedures
Competitive Landscape:
• Merz Pharma GmbH & Co. KGaA
• Cynosure, Inc. (Sub. Hologic Inc.)
• Tanceuticals, LLC.
• Inceler Medikal Co. Ltd.
• Cymedics
• Nubway
• Zimmer Aesthetics
• Syneron Medical Inc
Overall Market Approach:
• Research collaborations and partnerships between research institutes and technology companies is the prominent trend observed in global cellulite treatment market
• Adoption of newer marketing strategy by device manufacturers to attract problem suffering population effecting with normal requirement of these devices at lower price
Key Segments:
• Non-Invasive segment contributed highest market share and will continue to do so due to focused development of Rising prevalence of fat deposition related disorders requiring better treatment options
• Development of topical treatment would have higher impact on penetration
Target Country:
• The U.S. being highly growth market and possess expertise and resources, is expected to continue to dominate the global market
• Majority of manufacturers of cellulite treatment are focusing to launch their product in emerging market due to chances of early approval that by FDA
Differentiating Strategy:
• Manufacturers of cellulite treatment are focusing to raise capital required for launch of new products or research and development expenses through venture financing
• Company are also resorting to hiring of CMOs and CDMOs in order to reduce operational costs and improve overall productivity
Source: futuremarketinsights.com
